Acceptability and tolerability of long-acting injectable cabotegravir–rilpivirine in adolescents with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multicentre, open-label, non-comparative phase 1/2 trial
Year: 2026
Type: article
Source: The Lancet HIV
Authors: Elizabeth D Lowenthal, Jennifer Chapman, Kristin Baltrusaitis, Grace Kovic, Sanjna Merchant, Kaleb Branch, Chermiqua Tsosie, Martina Zapata Vaca, Barbara Heckman, Rodica M Van Solingen-Ristea, Conn M Harrington, Dwight E Yin, Ellen Townley, Michael Whitton, Allison L Agwu, Christiana Smith, Mary E Paul, Avy Violari, Evette Moodley, Maxensia Owor, Kulkanya Chokephaibulkit, Samantha Fry, Jennifer Jao, Charles D Mitchell, Sarah Buisson, Andi Ace, Irina Kolobova, Carolyn Bolton-Moore, Aditya H Gaur, Annie Buchanan, Jenny Huang, Eileen Birmingham, Kati Vandermeulen, Sisinyana Ruth Mathiba, Pradthana Ounchanum, Gaerolwe Masheto, Linda Aurpibul, Violet Korutaro, Faeezah Patel, Andres Camacho-Gonzalez
Institutions: Children's Hospital of Philadelphia, University of Pennsylvania, Harvard University, Frontier Science & Technology Research Foundation, Inc., National Institutes of Health, National Institute of Allergy and Infectious Diseases, Family Health International 360, Johns Hopkins University, University of Colorado Anschutz, Baylor College of Medicine, University of the Witwatersrand, Perinatal HIV Research Unit, Centre for the AIDS Programme of Research in South Africa, MUJHU Research Collaboration, Siriraj Hospital, Mahidol University, Northwestern University, University of Miami, Centre for Infectious Disease Research in Zambia, University of Alabama, University of Alabama at Birmingham, St. Jude Children's Research Hospital
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: St. Jude Children's Research Hospital, ViiV Healthcare, National Institutes of Health, Johnson and Johnson, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: G1857750563, SDMC - IMPAACT Leadership Group, International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network, Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU, CURE CTU, Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU), The Johns Hopkins University - Uganda Clinical Trials Unit, KwaZulu-Natal Clinical Trials Unit, PHRU-Setshaba Clinical Trials Unit, IMPAACT Leadership Group
OpenAlex ID: W7124265635